Beam Therapeutics
Price & Volume
Stats
See more52W Range | $15.60-$38.26 |
Market Cap | $3.3B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $164M |
Revenue Growth (YoY) | 324.9% |
Gross Profit (12 Mos) | -$240.9M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 2 days ago
Cathie Wood buys $22.8 million of surging tech stock
Yahoo Finance • 6 days ago
Prime Medicine gains after winning arbitration with Beam Therapeutics
Yahoo Finance • 16 days ago
Cathie Wood buys $11.5 million of battered tech stock
Yahoo Finance • last month
Draft FDA guidance could be a boon for gene therapy developers
About
CEO | Mr. John M. Evans M.B.A. |
Address | 238 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 522 |